Insider · CIK 0001856369

Gibson Christopher

CIK 0001856369 Name as filed on the most recent filing

Filed as Gibson Christopher (76)

227 transaction lines · from 76 filings · filed 2021-12-09 to 2026-06-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

227 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 144,800, disposed Open Form 4 filing 0001856369-26-000023
2026-05-22 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 123,200, disposed Open Form 4 filing 0001856369-26-000019
2026-05-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 134,800, disposed Open Form 4 filing 0001856369-26-000015
2026-04-22 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 144,400, disposed Open Form 4 filing 0001856369-26-000013
2026-04-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 124,000, disposed Open Form 4 filing 0001856369-26-000008
2026-03-23 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 130,000, disposed Open Form 4 filing 0001601830-26-000052
2026-02-19 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 138,400, disposed Open Form 4 filing 0001601830-26-000021
2026-02-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 164,800, disposed Open Form 4 filing 0001601830-26-000008
2026-01-20 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 178,800, disposed Open Form 4 filing 0001856369-26-000005
2026-01-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 170,000, disposed Open Form 4 filing 0001856369-26-000003
2025-12-19 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 180,000, disposed Open Form 4 filing 0001856369-25-000018
2025-12-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 185,200, disposed Open Form 4 filing 0001856369-25-000016
2025-11-19 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 166,400, disposed Open Form 4 filing 0001856369-25-000014
2025-11-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 208,400, disposed Open Form 4 filing 0001856369-25-000012
2025-10-23 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 570,000, disposed Open Form 4 filing 0001856369-25-000010
2025-10-10 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 604,000, disposed Open Form 4 filing 0001856369-25-000007
2025-09-25 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 476,000, disposed Open Form 4 filing 0001856369-25-000005
2025-09-10 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 471,000, disposed Open Form 4 filing 0001601830-25-000145
2025-08-26 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 484,000, disposed Open Form 4 filing 0001601830-25-000136
2025-08-11 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 3 lines 3,263,964, disposed Open Form 4 filing 0001601830-25-000130
2025-03-27 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 836,987, disposed Open Form 4 filing 0001601830-25-000051
2025-03-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 127,400, disposed Open Form 4 filing 0001601830-25-000037
2025-03-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 131,600, disposed Open Form 4 filing 0001601830-25-000037
2025-02-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 162,400, disposed Open Form 4 filing 0001601830-25-000014
2025-02-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 153,600, disposed Open Form 4 filing 0001601830-25-000014
2025-01-10 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 141,000, disposed Open Form 4 filing 0001601830-25-000010
2025-01-08 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 146,200, disposed Open Form 4 filing 0001601830-25-000010
2024-12-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 142,400, disposed Open Form 4 filing 0001601830-24-000234
2024-12-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 143,200, disposed Open Form 4 filing 0001601830-24-000234
2024-11-14 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 147,000, disposed Open Form 4 filing 0001601830-24-000207
2024-11-13 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 154,800, disposed Open Form 4 filing 0001601830-24-000207
2024-10-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 121,600, disposed Open Form 4 filing 0001601830-24-000172
2024-10-02 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 123,200, disposed Open Form 4 filing 0001601830-24-000172
2024-09-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 122,800, disposed Open Form 4 filing 0001601830-24-000155
2024-09-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 120,800, disposed Open Form 4 filing 0001601830-24-000155
2024-08-08 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 130,000, disposed Open Form 4 filing 0001601830-24-000122
2024-08-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 213,000, disposed Open Form 4 filing 0001601830-24-000122
2024-07-11 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 373,500, disposed Open Form 4 filing 0001601830-24-000103
2024-07-10 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 374,000, disposed Open Form 4 filing 0001601830-24-000103
2024-06-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 450,000, disposed Open Form 4 filing 0001601830-24-000077
2024-06-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 421,000, disposed Open Form 4 filing 0001601830-24-000077
2024-05-02 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 423,500, disposed Open Form 4 filing 0001601830-24-000047
2024-05-01 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 386,500, disposed Open Form 4 filing 0001601830-24-000047
2024-04-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 586,300, disposed Open Form 4 filing 0001628280-24-015103
2024-04-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 574,600, disposed Open Form 4 filing 0001628280-24-015103

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 227
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Gibson Christopher, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001856369

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.